Thursday, February 24, 2022

MAHE And bioMérieux To Establish Center Of Excellence In Antimicrobial Resistance And Antimicrobial Stewardship In South Asia


* Partnership to deliver high-value solutions, expertise, and service in Antimicrobial Stewardship to improve patient care

Manipal Academy of Higher Education and bioMérieux announced the signature of the framework agreement to create a Center of Excellence for Antimicrobial Resistance and Antimicrobial Stewardship. This new generation laboratory will be located at Kasturba Medical College, Manipal.

The increasing and inappropriate use of antibiotic treatment for both human and animal medicine is fueling the emergence and spread of resistant bacteria around the world. Common infectious diseases are becoming more and more difficult to treat, which is alarming for the entire healthcare community.

A recent report* by The Lancet estimates 1.27 million people die from Antimicrobial Resistance (AMR) each year. If no action is taken, AMR could lead to 10 million people dying every year by 2050, according to the World Health Organization**. Antimicrobial stewardship (AMS) is key to fighting resistance and sustaining antibiotic efficacy for future generations as it allows patients to get the right drug, at the right dose at the right time.

bioMérieux and Manipal Academy of Higher Education have a shared vision for the future of managing AMR & improving antimicrobial stewardship (AMS) initiatives. Through this agreement, Manipal Academy of Higher Education has become a partner of choice to define and demonstrate Medical & Economic value and data-driven best practices around AMS, to improve AMS interventions and showcase how throughout the medical community across South Asia. They are also collaborating in a clinical performance evaluation of new diagnostic solutions. Manipal Academy of Higher Education is using its unique panel of academic, technical, and business experts to address the topic of AMR & AMS.

As a world leader in in vitro diagnostics, bioMérieux provides its expertise in advanced diagnostic technologies, IT and lab automation, as well as training and quality management support. A dedicated team is accompanying Manipal Academy of Higher Education to support their AMS initiatives to optimize the use of antibiotics and fight against the transmission of multidrug-resistant organisms (MDROs). With its comprehensive range of diagnostic solutions and deep knowledge on data generation for and beyond the lab, bioMérieux will directly support frontline AMS stakeholders, including clinicians and pharmacists, with timely, integrated diagnostic insights to support patient therapy and stewardship intervention.

Lt. Gen. (Dr.) M. D. Venkatesh, Vice Chancellor of Manipal Academy of Higher Education said “We consider bioMérieux as a global partner with long-standing commitment & expertise in infectious disease diagnostics and a strong presence worldwide. We are convinced that working together will boost the efficiency and the quality of patient care and will show significant improvement in antimicrobial stewardship measures,”

Rajan Nagar, Vice President & General Manager – bioMérieux, South Asia added “We are extremely pleased by this partnership as we benefit from the expertise of the leading microbiologists and clinicians at Manipal Academy of Higher Education to fight against antimicrobial resistance and further develop antimicrobial stewardship solutions. We are convinced that rapid patient results and epidemiological information will enable microbiologists and clinicians to work together more closely and effectively with the aim of improving patient care.”

This landmark event was witnessed by Dr P L N G Rao, Pro Vice Chancellor, Dr Venkatraya Prabhu, Pro Vice Chancellor, Dr Narayana Sabhahit, Registrar, MAHE, Dr Chiranjay Mukhopadhyay, Associate Dean, Dr Krishnananda Prabhu, Associate Dean, Dr Vandana K E, Professor and Head, Department of Microbiology, from KMC, Manipal. The bioMérieux was represented by Mr Somnath Banerjee, Mr Soumyabrata Chakraborty and Dr Navjeet Singh.

* https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00087-3/fulltext

**https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis  About Manipal Academy of Higher Education

ABOUT Manipal Academy of Higher Education

Manipal is synonymous with excellence in higher education and MAHE is one of India's leading academic and research institutions. It has been granted Institution of Eminence status by the Ministry of Human Resource Development, Government of India. Manipal has created some of the country's best institutes/schools across several diverse streams and Kasturba Medical College being the jewel in the crown. Currently, in 300+ programs across 31 disciplines, over 28,000 students from 57 different nations live, learn, and play in the sprawling University town of Manipal. Research has always been an area of paramount importance at Manipal. The experts at Manipal are taking meticulous and meaningful steps to build reservoirs of intellectual wealth and academic excellence. MAHE promotes Innovation and Entrepreneurship among students, faculty, alumni as well as people of the region by providing required facilities & support.

Established in 1953, Kasturba Medical College has been the flagship institution of Manipal Academy of higher education which by itself is the top ranked private medical university in the country and an Institute of Eminence.  KMC, Manipal has been consistently ranked in the top 10 medical college in the country since many decades. The college is well supported by Kasturba Hospital, a premier tertiary center with 2032 beds and is the apex teaching hospital established in 1961. Other information can be found at www.manipal.edu

ABOUT BIOMÉRIEUX

Pioneering Diagnostics

A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of international sales (outside of France).

bioMérieux provides diagnostic solutions (systems, reagents, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. Corporate website: www.biomerieux.com.

ABOUT BIOMÉRIEUX’S COMPLETE ANTIMICROBIAL STEWARDSHIP (AMS) SOLUTION

One of bioMérieux’s healthcare missions is to help sustain the use of antibiotic efficiency for generations to come. To support hospitals, institutions and laboratories with their AMS programs, bioMérieux has a complete solution covering antibiotic therapy initiation, optimization and discontinuation. This constantly evolving offer provides labs with timely, accurate results to adjust therapy, transforms data into actionable insights and integrates smoothly into any hospital with its flexible partnership approach. bioMérieux has over 55 years of microbiology expertise with more than 75% of its R&D directed to AMR/AMS research to ensure the current offer evolves to meet customers’ AMS needs.

No comments:

Total Pageviews